Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
8.79B
Market cap8.79B
Price-Earnings ratio
-60.42
Price-Earnings ratio-60.42
Dividend yield
Dividend yield
Average volume
1.51M
Average volume1.51M
High today
$179.20
High today$179.20
Low today
$173.22
Low today$173.22
Open price
$176.31
Open price$176.31
Volume
828.38K
Volume828.38K
52 Week high
$228.88
52 Week high$228.88
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

Charles River(CRL) stock is priced at $178.61, giving the company a market capitalization of 8.79B. It carries a P/E multiple of -60.42.

On 2026-03-02, Charles River(CRL) stock traded between a low of $173.22 and a high of $179.20. Shares are currently priced at $178.61, which is +3.1% above the low and -0.3% below the high.

The Charles River(CRL)'s current trading volume is 828.38K, compared to an average daily volume of 1.51M.

During the past year, Charles River(CRL) stock moved between $91.86 at its lowest and $228.88 at its peak.

During the past year, Charles River(CRL) stock moved between $91.86 at its lowest and $228.88 at its peak.

CRL News

TipRanks 5d
Charles River: Portfolio Reshaping Improves Margins but Lowers Growth, Supporting Hold Rating

Analyst Kallum Titchmarsh of Morgan Stanley maintained a Hold rating on Charles River Labs, retaining the price target of $185.00. Claim 50% Off TipRanks Premiu...

Benzinga 6d
Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans

Charles River Laboratories (NYSE:CRL) on Wednesday announced significant plans to divest parts of its business. Charles River agreed to divest its CDMO and Cel...

Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans
TipRanks 6d
Charles River price target raised to $175 from $170 at UBS

UBS raised the firm’s price target on Charles River (CRL) to $175 from $170 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate...

Analyst ratings

53%

of 19 ratings
Buy
52.6%
Hold
42.1%
Sell
5.3%

More CRL News

TipRanks 6d
Iqvia to acquire certain discovery services assets from Charles River

Iqvia (IQV) announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories (CRL). These assets include...

Simply Wall St 7d
Assessing Charles River Laboratories Valuation After Earnings Beat And 2026 Improvement Guidance

Advertisement Why Charles River Laboratories International (CRL) Is Back on Investor Radar Charles River Laboratories International (CRL) has drawn attention...

Assessing Charles River Laboratories Valuation After Earnings Beat And 2026 Improvement Guidance

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.